Galaxy Digital, founded by Mike Novogratz, made its Nasdaq debut on Friday, capping off a momentous week for cryptocurrency ...

Mike Novogratz’s crypto firm Galaxy Digital began trading on the Nasdaq, completing a four-year effort to secure a U.S.

The Galaxy Watch heavily relies on tiles as one of the main ways wearers can access information from their devices, and they seem to do the job fine. Samsung wants to switch things up, according ...

Royalty Pharma reported 12% growth in Q1 royalty receipts, driven by Vertex, GSK, and Roche, with adjusted EBITDA reaching $738 million. The company raised its 2025 Portfolio Receipts guidance to ...

On Saturday, things hit a new low for the Los Angeles Galaxy, losing 7-0 to the New York Red Bulls, and it's now the worst start by a defending MLS Cup champion in history with zero victories ...

Despite the fact that the iPhone Fold display is being made by Samsung, it looks like it might be more advanced that the one so far used in the Korean company’s own Galaxy Z Fold series.

2025 /PRNewswire/ -- Cytoki Pharma ApS (Cytoki), a clinical-stage biotechnology company pioneering a new class of medicines that harness interleukin-22 (IL-22) biology to drive improved metabolic ...

Samsung is expected to announce a tri-fold phone in the coming months, called the Galaxy G Fold. The phone is expected to use silicon carbon tech in the battery, allowing it to be physically ...

LabVantage Pharma is the only pre-configured and pre-validated pharmaceutical LIMS in the world. This greatly lowers the deployment cost (85%) and time (75%) compared to a traditional LIMS ...

Produce high-quality, injectable drug delivery systems with the Thermo Scientific™ Pharma mini Implant Line. This automated end-to-end solution meets cGMP and FDA requirements. Accurate dosing ...

In 2025, pharma companies must enable an instantaneous data-to-decision value chain that is AI-powered, cloud-based, and product-enabled. You need to ingest data rapidly, manage it, keep it ...

Pharma trade organisations in the US have told President Trump that tariffs such as the 10% levy on Chinese imports could drive up the cost of generic medicines, impact supply chains, and ...